News for hackers. Stuff that matters.

jogagobburu

I think the key "emergency use" is missed. The question is what are we going to do when you need something right away in a pandemic situation. The point here has nothing to do with "avoiding" trials - that I will never advocate. But there are enough situations that require us to think "outside the box". at that point, magic cannot happen. we need build things systemically as science progresses...
USA for emergency use.
You are right, a portion of pharma is conservative. There are two different needs in Pharma - one is more like assembly line (pure operations) and other other is "innovation". One has to decide what excites scientists - operations (eg calculating group means over and over where the answer has to be exact) OR innovation (get the questions right, designs right, analysis right, answers approximately accurate). I think there is a place for "operations", but they constitute "sustaining innovations". Meaning can I find the most economical solution for this problem? Operations is a separate discussion.

Let us talk about "disruptive innovations". What if I told you I was part of the team that approved a treatment for H1N1 flu pandemic in children without ANY trial based on unapproved data in adults? What if I told you the development pathway for pulmonary arterial hypertension in pediatrics was driven by analysis performed by Pumas-like software to establish a reasonable endpoint? These are patients who cannot perform most daily functions we take for granted. There would have been no drugs approved otherwise. How can you, me and others contribute to the disruptive innovation which will transform how drugs are developed and patients are treated. Pumas is designed to disrupt drug development and precision medicine. There are plenty of opportunities for disruption in healthcare. these opportunities are the motivation for Pumas..Joga Gobburu (Co-Founder, Pumas-AI)